|
I am writing to share a meaningful change coming to The Journal of Applied Laboratory Medicine (JALM). Starting with the January 2026 issue, JALM will become a fully open access journal. This new publishing model means changes for both authors and readers. |
|
What does this mean for you? Every article will be available for anyone to read, immediately upon publication—no subscriptions required, no login barriers. Authors will also keep copyright to their work, making it easier to share, adapt, and reuse their work in ways that advance science and improve practice. Why is ADLM making this change? ADLM launched JALM in 2016 to translate cutting edge lab medicine research into real-world diagnostic and clinical practice. Open access is more than just a trend. It delivers on the journal’s mission by breaking down access barriers between discovery and application. Open access articles are read and cited more often. Researchers today are working in an environment where openness matters more than ever. Many funders now require open access publication. And readers—from clinicians to policymakers—need reliable information. As laboratory testing becomes more central to patient-centered care, digital health, and data-driven decision-making, open access affirms the leadership role of lab professionals in shaping the future of medicine. To support a smooth transition, JALM will waive all open access charges for a limited time:
Many authors may qualify for discounts or full waivers based on:
Frequently asked questions and answers are available at myadlm.org. For information about fees and eligibility, visit the JALM website. Please refer your questions to membership@myadlm.org. |